Dimensional Fund Advisors LP Orgenesis Inc. Transaction History

Dimensional Fund Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$1.01 - $1.44 $20,369 - $29,041	-20,168 Reduced 54.94%	16,541 $22,000
Q1 2023 May 12, 2023	BUY	$1.18 - $2.59 $354 - $777	300 Added 0.82%	36,709 $43,000
Q4 2022 Feb 09, 2023	BUY	$1.18 - $2.24 $14,160 - $26,880	12,000 Added 49.16%	36,409 $70,000
Q3 2022 Nov 10, 2022	SELL	$1.38 - $2.38 $7,468 - $12,880	-5,412 Reduced 18.15%	24,409 $35,000
Q2 2022 Aug 12, 2022	BUY	$1.8 - $3.74 $10,895 - $22,638	6,053 Added 25.47%	29,821 $72,000
Q1 2022 May 13, 2022	SELL	$2.31 - $3.72 $462 - $744	-200 Reduced 0.83%	23,768 $82,000
Q4 2021 Feb 09, 2022	SELL	$2.61 - $4.9 $3,356 - $6,301	-1,286 Reduced 5.09%	23,968 $69,000
Q3 2021 Nov 12, 2021	BUY	$4.6 - $5.44 $28,101 - $33,232	6,109 Added 31.91%	25,254 $125,000
Q2 2021 Aug 12, 2021	BUY	$4.19 - $5.88 $3,385 - $4,751	808 Added 4.41%	19,145 $97,000
Q1 2021 May 14, 2021	BUY	$4.77 - $8.08 $36,771 - $62,288	7,709 Added 72.53%	18,337 $105,000
Q4 2020 Feb 25, 2021	BUY	$4.4 - $5.63 $46,763 - $59,835	10,628 New	10,628 $48,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.